Tiziana Crepaldi

Title: Tiziana Crepaldi: Innovator in Tumor Treatment

Introduction

Tiziana Crepaldi is a notable inventor based in Turin, Italy. She has made significant contributions to the field of oncology through her innovative research and development of pharmaceutical compositions. With a total of 3 patents, her work focuses on treatments for tumors and metastasis.

Latest Patents

One of her latest patents is titled "Anti-Met fab-Fc for the treatment of a tumor and/or metastasis." This invention involves an anti-Met antibody fragment that comprises a single antigen binding arm and an Fc region. The antigen binding arm is defined by specific variable regions, making it useful in the treatment of tumors and metastasis. Another significant patent is "Pharmaceutical composition containing ezrin mutated on tyrosine 353." This invention relates to a pharmaceutical composition that includes an effective amount of ezrin mutated on tyrosine 353, aimed at preventing and treating tumors.

Career Highlights

Throughout her career, Tiziana has worked with various organizations, including Farmitalia Carlo Erba S.r.l. Her expertise in the pharmaceutical industry has allowed her to develop groundbreaking treatments that address critical health issues.

Collaborations

Tiziana has collaborated with esteemed colleagues such as Paolo Comoglio and Maria Prat. Their combined efforts have contributed to advancements in cancer treatment and research.

Conclusion

Tiziana Crepaldi's innovative work in the field of oncology has led to the development of important treatments for tumors and metastasis. Her contributions continue to impact the medical community positively.